About this trial
In our study, we assess the diaphragmatic function, pain quality and anti-inflammatory properties between low dose infusion of dexmedetomidine normal saline in patients with multiple fracture ribs on conservative treatment.
Eligibility criteria
Qualifiers
Adults (age 18-65 years) of American Society of Anaesthesiologists (ASA) physical status I-II
Traumatic multiple fracture ribs 3 ribs or more, who will be subjected to thorough assessments including chest 3D-CT
Undergoing conservative treatment (chest strappings)
Intractable pain with visual analogue scale (VAS) over 6 after traditional therapies
Disqualifiers
Multiple traumas to body parts other than chest with an abbreviated injury scale over 3
Serious head trauma with a Glasgow coma scale lower than 13
Mechanically ventilated patients
Massive hemothorax
Trial design
Treatments tested in this trial
- Dexmedetomidine
- 0.9% saline